Press release
AI in Clinical Trials Market Surges With The Escalating Incidence Of Chronic And Infectious Diseases: Core Growth Enabler in the AI in Clinical Trials Market, 2025
AI in Clinical Trials
What Will the AI in Clinical Trials Industry Market Size Be by 2025?
The market size of AI in clinical trials has expanded rapidly over the past few years. It is projected to rise from $6.57 billion in 2024 to $9.21 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 40.2%. The impressive growth during the historic period can be linked to the growing collection of data in the healthcare field, enhancements in computing power, backing from the FDA for AI, the emergence of wearable devices, and the initial development of AI algorithms.
What's the Long-Term Growth Forecast for the AI in Clinical Trials Market Size Through 2029?
In the coming years, an exponential increase is predicted for the market size of AI in clinical trials, with its worth projected to extend to $38.7 billion in 2029. This growth represents a compound annual growth rate (CAGR) of 43.2%. The upward trend during the forecast period is anticipated due to several factors such as integration of real-world data, patient recruitment powered by AI, identification of AI-driven biomarkers, optimization of AI-driven trial designs, and adoption of continuous monitoring technology. Foreseen trends for this period also encompass federated learning approaches, the application of AI in adaptive trials, AI-supported prediction of outcomes, AI-aided drug development, and AI-fueled drug repurposing.
View the full report here:
https://www.thebusinessresearchcompany.com/report/ai-in-clinical-trials-global-market-report
What Are the Key Growth Drivers Fueling the AI in Clinical Trials Market Expansion?
The growth of the AI in clinical trials market is anticipated to be driven forward due to increased occurrences of chronic and infectious diseases. Chronic diseases, illnesses that persist for more than three months and may worsen over time, can be treated using various drugs developed through AI in clinical trials. For example, data released by Macmillan Cancer Support, a UK-based cancer charity, in June 2022 revealed that cancer affected 3 million people that year and projected a hike to approximately 3.5 million by 2025 and 4 million by 2030 in the UK. Furthermore, as per the UK Health Security Agency, a UK executive agency, in August 2024, measles cases in England witnessed a nearly sevenfold surge, from 53 in 2022 to 368 in 2023. The West Midlands and London were the most affected regions accounting for 44% and 33% of these cases, respectively. Therefore, it is clear that increasing rates of chronic and infectious diseases are playing a key role in propelling the AI in the clinical trials market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11961&type=smp
What Are the Key Trends Driving AI in Clinical Trials Market Growth?
Technological progress is an emerging trend in the AI in clinical trials market. Firms in this sector are embracing innovative technology to maintain their market standing. For example, Lantern Pharma, a clinical-stage oncology company based in the U.S., launched its distinctive RADR AI and ML platform in February 2023 to transform the cost, pace, and time duration of discovering and developing oncology drugs. These RADR enhancements will focus on advanced AI and ML strategies to develop antibody-drug conjugates (ADCs), highly specific antibodies for cancer treatment that are linked to powerful anti-tumor small molecules.
How Is the AI in Clinical Trials Market Segmented?
The AI in clinical trials market covered in this report is segmented -
1) By Offering: Software, Services
2) By Process: Trial Design, Patient Selection, Site Selection, Patient Monitoring
3) By Technology: Machine Learning, Deep Learning, Supervised Learning, Other Technologies
4) By Application: Oncology, Neurological Diseases And Condition, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases, Immunology Diseases, Other Applications
5) By End-User: Pharmaceuticals And Biotechnology Companies, Contract Research Organizations, Other End-Users
Subsegments:
1) By Software: Clinical Trial Management Systems (CTMS), Data Analytics Software, Predictive Analytics Tools, Patient Recruitment And Retention Software, Real-World Evidence Platforms
2) By Services: Consulting Services, Data Management And Analysis Services, Training And Support Services, Regulatory Compliance Services
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=11961&type=smp
Which Companies Are Leading the Charge in AI in Clinical Trials Market Innovation?
Major companies operating in the AI in clinical trials market include Intel, The International Business Machines Corporation (IBM), Koninklijke Philips N.V., ConcertAI, Samaa Technologies, Owkin Inc., Numerate, Neuroute, AiCure, Ardigen, Unlearn AI, PathAI, Exscentia, Aitia Infotech Pvt Ltd., Euretos, VeriSIM Life, Envisagenics, NURITAs, BioSymetrics, BioAge Labs Inc, Trials.Ai, Pharmaseal, Caylx, IQVIA
Which Regions Are Leading the Global AI in Clinical Trials Market in Revenue?
North America was the largest region in the AI in clinical trials market in 2024. The regions covered in the AI in clinical trials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11961
This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release AI in Clinical Trials Market Surges With The Escalating Incidence Of Chronic And Infectious Diseases: Core Growth Enabler in the AI in Clinical Trials Market, 2025 here
News-ID: 4097202 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Trial
Clinical Trial Investigative Site Network Market Clinical Trial Investigative Si …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Clinical Trial Investigative Site Network Market - (By Therapeutic Areas (Oncology, Cardiology, CNS, Pain Management, Endocrine, Others), By Phase (Phase I, Phase II, Phase III, Phase IV), By End-use (Sponsor, CRO)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic, the Global Clinical Trial Investigative Site Network Market…
Transformative Trends Impacting the Electronic Trial Master File (eTMF) Systems …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Electronic Trial Master File (eTMF) Systems Market Size By 2025?
The market size of the electronic trial master file (eTMF) systems has experienced fast growth over recent years. The market is projected to increase from $1.36 billion in 2024 to $1.55 billion in 2025, with…
Transformative Trends Impacting the Electronic Trial Master File (eTMF) Systems …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Electronic Trial Master File (eTMF) Systems Market Size By 2025?
The market size of the electronic trial master file (eTMF) systems has experienced fast growth over recent years. The market is projected to increase from $1.36 billion in 2024 to $1.55 billion in 2025, with…
Clinical Trial Management System
According to a new market report published by Persistence Market Research “Global Market Study on Clinical Trial Management System: Asia to Witness Highest Growth by 2019” the global clinical trial management system market was valued at USD 844.0 million in 2013 and is expected to grow at a CAGR of 14% from 2014 to 2019, to reach an estimated value of USD 1,848.5 million in 2019.
Request Report TOC @ https://www.persistencemarketresearch.com/methodology/3017
…
Clinical Trial Logistics
Clinical Trial Logistics
16th to 17th May 2011, Marriott Regents Park, London, United Kingdom.
It currently costs just over £500 million ($800 million) to bring a new chemical to market and development timelines continue to fall in the 10-15 year range. A key reason for high R&D costs is due to logistical failures including failure to recruit patients on time. A way to avoid this is to move clinical trials…
Clinical Trial Logistics
Announcing SMi's 5th annual…
Clinical Trial Logistics conference
16th and 17th May 2011, Central London, UK
www.smi-online.co.uk/2011logistics-london6.asp
It currently costs just over £500 million ($800 million) to bring a new chemical to market and development timelines continue to fall in the 10-15 year range. A key reason for high R&D costs is due to logistical failures including failure to recruit patients on time. A way to avoid this is to move clinical…
